Nextensa (CHIX:NEXTAB) Research & Development: €0.0 Mil (TTM As of Dec. 2025)


CHIX:NEXTAB Nextensa SA CHIX:NEXTAB
78 GF Score
Price €43.60
GF Value €36.77
! 5 Warning Signs
View Full Analysis

What is Nextensa Research & Development?

Nextensa CHIX:NEXTAB 78 Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus rates CHIX:NEXTAB with a GF Score™ of 78/100 and a GF Value™ of €36.77. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nextensa's Research & Development for the three months ended in Dec. 2025 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.0 Mil.

Nextensa  (CHIX:NEXTAb) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nextensa Research & Development Related Terms

Nextensa Research & Development Historical Data

* Premium members only.

The historical data trend for Nextensa's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nextensa Research & Development Chart

Nextensa Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nextensa Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:NEXTAB
78GF Score
Nextensa SA CHIX:NEXTAB
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nextensa Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.0 Mil mean?
Nextensa (CHIX:NEXTAB) has a Research & Development of €0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nextensa and its competitors.
Is Nextensa's Research & Development too high?
Nextensa's current Research & Development is €0.0 Mil. Overall, Nextensa has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Nextensa's Research & Development compare to VICI and WPC?
Nextensa's Research & Development of €0.0 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a REITs company?
A good Research & Development depends on the REITs industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nextensa and its competitors. Nextensa's current Research & Development is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nextensa stock overvalued right now?
Nextensa (CHIX:NEXTAB) has a current Research & Development of €0.0 Mil. The stock's GF Value™ is €36.77, compared to a current price of €43.60 — trading 18.6% above its estimated fair value. The current Research & Development is €0.0 Mil. Nextensa's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nextensa (CHIX:NEXTAB), the current Research & Development is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nextensa (CHIX:NEXTAB) Overvalued in 2026?

Based on GuruFocus' analysis, Nextensa stock appears to be overvalued. The current stock price of €43.60 is trading 18.6% above its estimated GF Value™ of €36.77.

Key valuation signals for CHIX:NEXTAB:

  • Research & Development: €0.0 Mil
  • GF Value™: €36.77 vs. price of €43.60 (18.6% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the CHIX:NEXTAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nextensa Business Description

Industry Real EstateREITs
Other Exchanges 0NUT:UKNEXTA:Belgium
Address Rue Picard 11, PO Box 505, Gare Maritime, Brussels, BEL, 1000
Nextensa SA operates as a real estate investment trust. It operates as a real estate investor and developer, managing an investment portfolio of real estate assets across Belgium, Austria, and Luxembourg. The company's portfolio mainly comprises offices, retail, semi-industrial, and logistics properties. Nextensa NV is composed of three operational segments, namely investment, development, and corporate. These segments are divided into sub-segments, namely Belgium, the Grand Duchy of Luxembourg, and Austria for the investment segment, and Belgium, Luxembourg, and other countries for the development segment. The company generates maximum revenue from Belgium in the form of rental income from investment properties.
78GF Score

Get the complete analysis for CHIX:NEXTAB

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.60
Price
€36.77
GF Value